Navigation Links
HERCULES Trial Demonstrates Significant Reduction in Systolic Blood Pressure While Revealing Marker in Hypertensive Patients Does Not Predict Outcomes of Renal Artery Stenting
Date:5/5/2011

BALTIMORE, May 5, 2011 /PRNewswire/ -- A substance secreted by the heart that is associated with congestive heart failure and renal failure is not predictive of reduction in systolic blood pressure in patients treated with renal artery stenting, according to results from the HERCULES trial presented as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions in Baltimore.

The HERCULES trial is a prospective, multicenter trial of renal stenting in patients who have blockages to their renal arteries, which can worsen hypertension and threaten kidney function. The study reviewed outcomes for 202 patients (241 lesions) with uncontrolled hypertension who were treated with a renal artery stent between August 2007 and October 2009. The primary endpoint was 9-month restenosis rate and the secondary endpoints included changes in blood pressure, anti-hypertensive medications, renal function and the predictive value of brain natriuretic peptide (BNP).  

The primary endpoint of the study was met, with a 9-month restenosis rate of 10.5 percent (p<0.0001), which was significantly lower than the performance goal of 28.6 percent. Results for the secondary endpoints showed systolic blood pressure (SBP) decreased significantly after stenting with no change in medication requirements, but mean BNP levels remained elevated after one month. The study found no evidence of a correlation between elevated pre-treatment BNP levels and SBP reduction at follow-up.  Researchers measured BNP prior to treatment, at 24 hours and 30 days.

"The clinical results are promising, as we found very low restenosis rates and a significant drop in blood pressure following renal artery stenting," said Michael R. Jaff, D.O., medical director of the Vascular Center at Massachusetts General Hospital in Boston. "One goal of the study was to identify a means to predict which patients will have the best outco
'/>"/>

SOURCE Society for Cardiovascular Angiography and Interventions (SCAI)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
2. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Stryker Corporation (NYSE: SYK ) announced ... of Porex Corporation. Porex Surgical is a developer, manufacturer ... use primarily in reconstructive surgery of the head and ... market with strong brand recognition and considerable clinical data ...
... Pursuant to the provisions of Section 7 paragraph 1(a) ... Biedingen Wft) requiring a public announcement within four weeks following ... status update, Johnson & Johnson (NYSE: JNJ ) ... Swiss Exchange: CRX) provide the following joint update. ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
(Date:4/17/2014)... Men who show signs of chronic inflammation in non-cancerous ... actually having prostate cancer than those with no inflammation, ... researchers from the Johns Hopkins Kimmel Cancer Center. , ... stronger for men with so-called high-grade prostate cancer ... indicating the presence of the most aggressive and ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... food and fluids during labour does not provide any ... University Associate Professor., "Based on our review, there is ... fluids, and perhaps food, for women during labour. ... Dr. Joan Tranmer of the Queen,s School of ...
... English-speaking Hispanic moms spend more time in front of ... News) -- Young children of Hispanic mothers whose main ... Hispanic moms who speak mostly English, a U.S. study ... 1,332 Hispanic and white mothers with children aged 4 ...
... ... system, Applicant Tracking System and Screening services. , ... Citrus Heights, CA (PRWEB) February 2, 2010 -- HR ... and efficient HRIS system, a web-based paperless Applicant Tracking System and an accurate, timely ...
... , MOUNT LAUREL, N.J. , Feb. 2 ... to announce the opportunity for individuals interested in voluntary service ... manager certification program in the United States . ... credential, CCMC is dedicated to upholding rigorous standards for its ...
... , Feb 2 The following news advisory was ...   Thirty-two Clear Channel stations nationwide will hold local radiothons ... , one of the world,s premier centers for the research and ... most organizations, St. Jude has not been immune to the effects ...
... might not be accurately diagnosed, Patients who do not have ... work, Calls for a briefer definition of the DSM-IV criteria ... led by Mark Zimmerman, MD, of Rhode Island Hospital indicates ... of psychiatrists reported that they often do not use the ...
Cached Medicine News:Health News:Spanish-Speaking Mothers Less Likely to Turn on TV 2Health News:HR Allen Provides Businesses with Three New Services. 2Health News:HR Allen Provides Businesses with Three New Services. 3Health News:CCMC Accepting Applications for Voluntary Service on its Board of Commissioners 2Health News:CCMC Accepting Applications for Voluntary Service on its Board of Commissioners 3Health News:32 Clear Channel Radio Stations Nationwide Unite to Fight Childhood Cancer February 11-12 2Health News:Study: Many physicians not using established criteria 2Health News:Study: Many physicians not using established criteria 3
... leads are small profile endocardial permanent pacing ... a lead body size of only 4.8 ... 7 F, the Physique lead is the ... Available in both straight and pre-formed J ...
Used with Temporary Myocardial Heartwires....
Used with permanent pacing leads....
Suture sleeve for permanent pacing leads....
Medicine Products: